CNS Disorders

Canadian Guidelines:

• Anxiety Disorders Association of Canada: Canadian Clinical Practice Guidelines for the Management of Anxiety, Posttraumatic Stress and Obsessive-compulsive Disorders (2014)
• Canadian Psychiatric Association: Management of Anxiety Disorders (2006)

Other Guidelines:

• NICE Pathway: Generalised Anxiety Disorder (UK, 2015)
• NICE Pathway: Social Anxiety Disorder (UK, 2015)
• NICE Guideline: Social Anxiety Disorder: Recognition, Assessment and Treatment (UK, 2013)
• NICE Guideline: Generalised Anxiety Disorder and Panic Disorder (with or without agoraphobia) in Adults: Management in Primary, Secondary and Community Care (UK, 2011)
• American Psychiatric Association: Treatment of Patients with Panic Disorder (US, 2009)

Canadian Guidelines:

• Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines (2018)

Other Guidelines:

• NICE Pathway: Attention Deficit Hyperactivity Disorder (UK, 2015)
• American Academy of Pediatrics: Diagnosis, Evaluation, and Treatment of ADHD  (US, 2011)
• NICE Guideline: Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults (UK, 2008)

Canadian Guidelines:

• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD): Management of Patients with Bipolar Disorder (2018)

Other Guidelines:

• NICE Pathway: Bipolar Disorder (UK, 2015)
• NICE Guideline: Bipolar Disorder (UK, 2018)
• American Psychiatric Association: Treatment of Patients With Bipolar Disorder 2nd ed. (US, 2002)

Canadian Guidelines:

• Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: Dementia (2014) 

Other Guidelines:

• NICE Pathway: Dementia (UK, 2015)
• NICE Guideline: Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers (UK, 2018)

Canadian Guidelines:

• Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments (2016)
• Canadian Psychiatric Association: Treatment of Depressive Disorders (2001)

Other Guidelines:

• NICE Pathway: Depression (UK, 2015)
• NICE Guideline: Depression in Children and Young People: Identification and Management in Primary, Community and Scondary Care (UK, 2017)
• American Psychiatric Association: Treatment of Patients with Major Depressive Disorder (US, 2010)
• NICE Guideline: Depression in Adults: Recognition and Management (UK, 2018)

Canadian Guidelines:

• Canadian Medical Association and Toward Optimized Practice: Diagnosis to Managment of Adult Primary Insomnia (2010)

Other Guidelines:

• American Academy of Sleep Medicine: Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults  (US, 2008)
• NICE Guideline: Guidance on the Use of Zalepon, Zolpidem, and Zopiclone for the Short-term Management of Insomnia (UK, 2004)

Canadian Guidelines:

• Canadian Guideline for Parkinson disease, 2nd Edition (2019)

Other Guidelines:

• NICE Pathway: Parkinson's Disease (UK, 2015)
• American Acedemy of Neurology: Initiation of Treatment for Parkinson's Disease (US, 2005)
• NICE Guideline: Parkinson's Disease in Adults (UK, 2017)

• National Institute of Mental Health (US)
• American Psychological Association (US)
• The American College of Obstetricians and Gynecologists
• Canadian Psychological Association
• Postpartum Depression (Merck Manual)
• Pregnancy and Women's Mental Health in Canada (Government Canada)

Canadian Guidelines:

• Epilepsy Implementation Task Force: Provincial Guidelines for the Management of Epilepsy in Adults and Children (Ontario, 2015)

Other Guidelines:

• NICE Pathway: Epilepsy (UK, 2015)
• International League Against Epilepy: Evidence Review of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes (Int'l, 2013)
• NICE Guideline: The Epilepsies: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care (UK, 2018)
• American Academy of Neurology & American Epilepsy Society: Treatment of New-onset Epilepsy (US, 2018)
• American Acedemy of Neurology & American Epilepsy Society: Treatment-resistant Epilepsy (US, 2018)

Canadian Guidelines:

• Canadian Psychiatric Association: Treatment of Schizophrenia (2005)

Other Guidelines:

• NICE Pathway: Psychosis and Schizophrenia (UK, 2015)
• NICE Guideline: Psychosis and Schizophrenia in Adults: Treatment and Management (UK, 2014)
• NICE Guideline: Psychosis and Schizophrenia in Children and Young People: Recognition and Management (UK, 2016)
• Scottish Intercollegiate Guidelines Network: Management of Schizophrenia (UK, 2013)
• American Psychiatric Association: Treatment of Patients with Schizophrenia (US, 2004)

*Recommended texts & electronic resources are linked to publishers' or book sellers' websites for further ordering information

• Bradley’s Neurology in Clinical Practice (Daroff, Jankovic, Mazziotta, Pomeroy, 7th ed., 2016) - $
  
• The APhA Complete Review for Pharmacy (Feeney, 11 ed. 2015)
  • see Chapter 28: Seizure Disorders
• Memory Loss, Alzheimer’s Disease, and Dementia (Budson and Solomon, 2nd ed., 2016) - $
  
• Principles and Practice of Sleep Medicine (Kryger, Roth, Dement, 6th ed., 2017) - $
  
• Stroke (Grotta, Albers, Broderick, Kasner, Lo, Mendelow et al., 6th ed., 2016) - $
  
• SwitchRx: The Online Psychiatric Medication Switching Tool.